🎥2024 SAPA Annual Conference Interview with Dr. Ying Huang: Exploring the Future of Cell Therapy and Career Development.

Join us for an insightful interview featuring Dr. Ying Huang, CEO of Legend Biotech, as he sits down with Jiaying Liu, Director of SAPA Global Communication, at the SAPA (Sino-American Pharmaceutical Professionals Association) 2024 Annual Conference held in New Brunswick, NJ, on September 27-28.

Dr. Huang gave a keynote speech on Saturday , September 28th, reviewing Legend Biotech advancements and breakthroughs over the past decade, particularly in blood cancer treatment. Following the conference, Dr. Huang was interviewed and shared his insights on the future of cell therapy and his unique career journey.

Highlights of the interview:
💎Dr. Huang acknowledged SAPA’s important role in fostering professional development and suggested inviting guest speakers from diverse fields to share their knowledge and career experience.
💎As for cell therapy, he emphasized the need to expand applications beyond blood cancers to solid tumors and autoimmune diseases. He also outlined challenges faced by current T cell therapy related to manufacturing and accessibility, highlighting the potential of allogeneic cell therapies and in vivo CAR T.
💎With a career spanning science, finance, and biotech leadership, Dr. Huang encouraged scientists to keep an open mind, seek roles aligned with their passions, and explore broader career opportunities beyond the lab.

🔗Stay tuned for more exclusive content and thought leadership from SAPA! Don’t forget to like, comment, and subscribe for more updates and interviews from key figures in the pharmaceutical and biotech industry.

#SAPA2024 #LegendBiotech #CellTherapy #Careerdevelopment #industryleader #scientificinnovation

свернуть